Design, Synthesis, and Biological Evaluation of Imidazopyrazinone Derivatives as Antagonists of Inhibitor of Apoptosis Proteins (IAPs)
- Authors
- Kim, Jisook; Bae, Inhwan; Song, Jiyoung; Kim, Younghoon; Ahn, Younggil; Park, Hyun-Ju; Kim, Ha Hyung; Kim, Dae Kyong
- Issue Date
- Jun-2021
- Publisher
- WILEY-V C H VERLAG GMBH
- Keywords
- Imidazopyrazinone; Inhibitors of apoptosis proteins antagonist; Second mitochondrial activator of caspases; Apoptosis
- Citation
- BULLETIN OF THE KOREAN CHEMICAL SOCIETY, v.42, no.6, pp 847 - 851
- Pages
- 5
- Journal Title
- BULLETIN OF THE KOREAN CHEMICAL SOCIETY
- Volume
- 42
- Number
- 6
- Start Page
- 847
- End Page
- 851
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/50728
- DOI
- 10.1002/bkcs.12271
- ISSN
- 0253-2964
1229-5949
- Abstract
- Apoptosis inhibitor (IAP) proteins are overexpressed in many cancers and implicated in tumor growth, so the development of antagonist that disrupts with the binding of IAP to their partner protein is a promising therapeutic strategy. In an effort to increase cellular activity and improve favorable drug-like properties, we newly designed and synthesized monovalent analogues based on imidazopyrazinone structure of 9. Optimization of cellular potency led to the identification of 17, which showed increase of submicromolar activity (GI(50) = 234 nM) and caspase-3 activation (6.3-fold) in MDA-MB-231 breast cancer cells. These findings clearly show the potential for 17 as a promising monovalent antagonist for the development of an effective anticancer treatment.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Pharmacy > School of Pharmacy > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/50728)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.